Equity Purchase and Funding Agreement Sample Contracts
EQUITY PURCHASE AND FUNDING AGREEMENT BY AND BETWEEN THERAVANCE BIOPHARMA, INC. AND ROYALTY PHARMA INVESTMENTS 2019 ICAV JULY 13, 2022Equity Purchase and Funding Agreement • July 14th, 2022 • Theravance Biopharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 14th, 2022 Company Industry JurisdictionThis EQUITY PURCHASE AND FUNDING AGREEMENT, dated as of July 13, 2022 (this “Agreement”), is entered into by and between Theravance Biopharma, Inc., a Cayman Islands exempted company (the “Seller”), and Royalty Pharma Investments 2019 ICAV, an Irish collective asset-management vehicle (the “Purchaser”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in Section 1 below.